DELFI Diagnostics Secures New York Approval for AI-Powered Lung Cancer Blood Test
PALO ALTO, California, May 28, 2026 DELFI Diagnostics has achieved a significant regulatory milestone after receiving a Clinical Laboratory...
AI diagnostics
Advertisement
Subtle Medical Gains FDA Clearance for SubtleHD PET
MENLO PARK, Calif., May 27, 2026 Subtle Medical, a leading developer of AI-powered medical imaging software, has announced that...
TOBY Gains FDA Breakthrough Status for Alzheimer’s Test
AUSTIN, Texas, May 26, 2026 TOBY, Inc., a biotechnology company focused on non-invasive disease detection technologies, has announced that...
Gene Solutions Wins FDA Breakthrough Status for SPOT-MAS 10
SINGAPORE, May 28, 2026 Gene Solutions announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device...
RADIN and AZmed Secure Expanded FDA Clearance for AZtrauma AI
Sheridan, Wyoming, USA – May 21, 2026 RADIN Health and medical imaging AI company AZmed announced a major expansion...
Advertisements
DELFI Diagnostics Expands Blood-Based Lung Screening
PALO ALTO, Calif., May 13, 2026 DELFI Diagnostics announced that it will present the first-ever clinical utility data for...
Ribo and Boehringer Advance siRNA MASH Program
SUZHOU, China, May 6, 2026 Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB announced the achievement of...
HelioLiver Blood Test Shows Strong HCC Detection
IRVINE, Calif., May 6, 2026 Helio Genomics announced publication of landmark clinical data demonstrating that its HelioLiver™ multi-analyte blood...
Roche to Acquire PathAI in $1.05 Billion AI Diagnostics Deal
BASEL, Switzerland – May 7, 2026 Roche announced it has entered into a definitive merger agreement to acquire PathAI,...
Castle Biosciences Unveils TissueCypher Data at DDW 2026
FRIENDSWOOD, TEXAS, May 04, 2026 Castle Biosciences has announced the presentation of new clinical data at Digestive Disease Week...
Advertisement
